WASHINGTON, Oct. 25 -- Fourteen State Attorneys General have submitted a public comment letter to the Election Assistance Commission urging the agency to revise its regulations to mandate documentary proof of citizenship for voter registration in federal elections. The letter, which responds to a petition for rulemaking from the America First Legal Foundation, emphasizes the need for stricter measures to ensure the integrity of voter registration processes. In their communication, the state off  more

WASHINGTON, Oct. 25 -- Sixteen State Attorneys General submitted a public comment letter to the U.S. Department of Education expressing opposition to a proposed revision regarding the collection of significant disproportionality data under the Individuals with Disabilities Education Act (IDEA). The states argue that the revision would undermine efforts to promote equity in special education by eliminating the current requirements for states to report changes in their methodologies for calculatin  more

WASHINGTON, Oct. 25 -- The Association for Behavioral Health and Wellness (ABHW) has issued a public comment letter to the Food and Drug Administration (FDA) emphasizing a pressing need for clear regulations on generative artificial intelligence-enabled digital mental health devices. The letter, delivered by the organization's leadership, addresses the critical distinctions between generative AI tools and evidence-based digital mental health therapeutics. ABHW, which represents payers managing   more

WASHINGTON, Oct. 25 -- The American Psychiatric Association (APA) has issued a public comment letter to the Food and Drug Administration (FDA) advocating for a comprehensive regulatory framework governing generative artificial intelligence (AI)-enabled digital mental health medical devices. As the national medical specialty society representing over 39,200 psychiatrists, APA emphasizes the need to ensure that AI's integration into mental health care prioritizes patient and physician welfare, sci  more

WASHINGTON, Oct. 25 -- Americans for Tax Reform (ATR) has submitted a public comment letter to the Consumer Financial Protection Bureau (CFPB) urging the agency to reconsider its Personal Financial Data Rights rule. ATR expressed concern over the implications of the regulation initially established under the Biden administration, referring to it as "unworkable" and harmful to both consumers and the financial sector. The ATR letter highlights that the current implementation of Section 1033 of th  more

WASHINGTON, Oct. 25 -- Andreessen Horowitz (a16z), Menlo Park, California, has submitted a public comment letter to the Financial Crimes Enforcement Network (FinCEN) advocating for a two-year delay in the implementation of the Anti-Money Laundering/Countering the Financing of Terrorism Program and Suspicious Activity Report Filing Requirements for Registered Investment Advisers and Exempt Reporting Advisers, commonly referred to as the IA AML Rule. This extension from January 1, 2026, to January  more

WASHINGTON, Oct. 25 -- The Alliance for Regenerative Medicine (ARM) has submitted a public comment letter to the Food and Drug Administration (FDA) following a listening session aimed at improving the regulatory landscape for cell and gene therapies (CGT). ARM, representing over 400 members including biotechnology developers and patient organizations, advocates for a clearer framework that leverages prior data and knowledge to facilitate the development and review of innovative therapies. In it  more

WASHINGTON, Oct. 25 -- Betterment, New York, has submitted a public comment letter to the Consumer Financial Protection Bureau (CFPB) expressing support for the Personal Financial Data Rights (PFDR) Rule and advocating for revisions that would enhance consumer data sharing rights. The letter addresses the Bureau's Advance Notice of Proposed Rulemaking (ANPR) regarding the reconsideration of the PFDR Rule, originally finalized in 2024 under the Dodd-Frank Act. In its letter, Betterment emphasize  more

WASHINGTON, Oct. 25 -- The Boston University School of Law, Massachusetts, has submitted a public comment letter to the U.S. Food and Drug Administration (FDA) supporting existing citizen petitions aimed at safeguarding access to mifepristone. These petitions urge the FDA to eliminate the restrictive Risk Evaluation and Mitigation Strategy (REMS) associated with mifepristone, which they argue impedes patient access to this essential medication. The letter emphasizes that medication abortion rem  more

WASHINGTON, Oct. 25 -- The Coalition on Human Needs (CHN) has submitted a public comment letter to the U.S. Department of Education expressing opposition to the proposed removal of "Significant Disproportionality" data collection from the Annual State Application under Part B of the Individuals with Disabilities Education Act (IDEA). This proposal, published in the Federal Register, has raised concerns among various organizations dedicated to supporting the rights and education of students with   more

WASHINGTON, Oct. 25 -- The Connected Health Initiative (CHI) has issued a public comment letter to the Food and Drug Administration (FDA) highlighting critical considerations for the regulation of Generative Artificial Intelligence (AI)-enabled digital mental health medical devices. This submission coincides with the upcoming meeting of the FDA's Digital Health Advisory Committee (DHAC) scheduled for November 6, 2025. In its letter, CHI emphasizes the need for FDA's regulatory frameworks to evol  more

WASHINGTON, Oct. 25 -- The Consortium for Constituents with Disabilities (CCD) Education Task Force has submitted a public comment letter to the U.S. Department of Education calling for the retraction of a proposal that aims to eliminate the collection of Significant Disproportionality data under the Individuals with Disabilities Education Act (IDEA). The task force argues that the proposal undermines established efforts to address racial disparities in special education and lacks accountability  more

WASHINGTON, Oct. 25 -- The Consumer Choice Center, an independent advocacy group focused on consumer rights, has submitted a public comment letter to the Consumer Financial Protection Bureau (CFPB) urging modifications to Section 1033 of the Dodd-Frank Act regarding the portability of financial data. The organization argues that open banking principles are essential for consumer autonomy and choice in the financial sector. In its letter, the Consumer Choice Center emphasized the importance of c  more

WASHINGTON, Oct. 25 -- Geron Corp., Foster City, California, has submitted a public comment letter to the Food and Drug Administration (FDA) expressing its views on the agency's Draft Guidance for Industry regarding the development of drug and biological products for treating Myelodysplastic Syndromes (MDS). The letter, dated October 17, highlights several areas where Geron believes the guidance could benefit from revisions, particularly in light of the evolving treatment landscape for MDS. In   more

WASHINGTON, Oct. 25 -- Hey Jane, New York, a telehealth provider specializing in reproductive and sexual healthcare, has submitted a public comment letter to the Food and Drug Administration urging the elimination of current restrictions on mifepristone access under the Single Shared System Risk Evaluation and Mitigation Strategies (REMS) Program. The letter specifically supports several citizen petitions related to this issue, calling for measures that minimize barriers to patient access to the  more

WASHINGTON, Oct. 25 -- The National Foreign Trade Council (NFTC) has submitted a public comment letter to the U.S. Department of Commerce regarding the ongoing investigation under Section 232 of the Trade Expansion Act, which is examining imports of robotics and industrial machinery and their potential impact on national security. The organization emphasizes the essential role that these imports play in maintaining U.S. competitiveness and innovation in the manufacturing sector. In its letter,   more

WASHINGTON, Oct. 25 -- Noam Inc., Palo Alto, Palo Alto, CA, has submitted a public comment letter to the U.S. Department of Transportation nominating CEO Lukasz "Luke" Gotszling for membership on the Research, Engineering, and Development Advisory Committee (REDAC). The company highlights Gotszling's extensive experience in technology and leadership as qualities that align with the FAA's objectives in enhancing the aviation sector. The nomination emphasizes Gotszling's role in developing an inn  more

WASHINGTON, Oct. 25 -- Spring Health, New York, has submitted a public comment letter to the Food and Drug Administration urging the agency to engage thoughtfully with the evolving field of generative artificial intelligence (AI) in digital mental health medical devices. The letter aligns with the upcoming meeting of the FDA's Digital Health Advisory Committee, scheduled for November 6, focusing on the regulation and oversight of AI-enabled mental health tools. In its letter, Spring Health emph  more

WASHINGTON, Oct. 25 -- The Arc of the U.S. has submitted a public comment letter to the U.S. Department of Education opposing a proposal to eliminate data reporting requirements regarding significant disproportionality under IDEA. The organization warns that this proposal could undermine efforts to address racial and ethnic disparities in special education. The Arc, which advocates for individuals with intellectual and developmental disabilities (IDD) across its nearly 600 chapters nationwide,   more

WASHINGTON, Oct. 25 -- Wise, New York, submitted a public comment letter to the Consumer Financial Protection Bureau (CFPB) advocating for the protection and enhancement of consumer financial data rights. The letter emphasizes the importance of maintaining consumer control over financial data as the Bureau reassesses the Personal Financial Data Rights Rule. In the letter, Wise applauded the CFPB for reopening discussions on the rule, which is crucial for empowering consumers in an increasingly   more